Oxford Biodynamics launches prostate screening test by John Pinching | Sep 26, 2023 | News | 0 EpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate Read More
Oxford BioDynamics signs deal to develop ASD biomarkers by Selina McKee | Nov 13, 2018 | News | 0 Oxford BioDynamics, Italian research institute pair to develop biomarkers for autism spectrum disorder (ASD). Read More